TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).

Craig L Slingluff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.